These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38643856)

  • 1. Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8
    Duan ZL; Zou WW; Chen D; Zhu JY; Wen JS
    Virus Res; 2024 Jul; 345():199376. PubMed ID: 38643856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis.
    Chen D; Duan Z; Zhou W; Zou W; Jin S; Li D; Chen X; Zhou Y; Yang L; Zhang Y; Shresta S; Wen J
    J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32501510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
    He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
    Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
    Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J
    Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
    Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
    Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.
    Li SH; Li XF; Zhao H; Jiang T; Deng YQ; Yu XD; Zhu QY; Qin ED; Qin CF
    Immunol Lett; 2011 Aug; 138(2):156-60. PubMed ID: 21515306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
    Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
    Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection.
    Tarbe M; Dong W; Hu G; Xu Y; Sun J; Grayo S; Chen X; Qin C; Zhao J; Liu L; Li X; Leng Q
    Front Immunol; 2020; 11():577546. PubMed ID: 33101303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
    Lima NS; Moon D; Darko S; De La Barrera RA; Lin L; Koren MA; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Modjarrad K; Douek DC; Trautmann L
    Front Immunol; 2021; 12():640190. PubMed ID: 33717194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection.
    Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z
    Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre-existing cellular immunity to Japanese encephalitis virus heterotypically protects mice from Zika virus infection.
    Zhang W; Xu Y; Zhao F; Tarbe M; Zhou S; Wang W; Zhang S; Zhang W; Xu Q; Shi L; Yuan F; Lin X; Liu S; Sun J; Zhao J; Yang Y; Liang X; Zhong J; Long G; Qin C; Leng Q; Tang H
    Sci Bull (Beijing); 2020 Mar; 65(5):402-409. PubMed ID: 36659231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
    Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue virus-reactive CD8
    Wen J; Elong Ngono A; Regla-Nava JA; Kim K; Gorman MJ; Diamond MS; Shresta S
    Nat Commun; 2017 Nov; 8(1):1459. PubMed ID: 29129917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.
    Shukla R; Shanmugam RK; Ramasamy V; Arora U; Batra G; Acklin JA; Krammer F; Lim JK; Swaminathan S; Khanna N
    EBioMedicine; 2020 Apr; 54():102738. PubMed ID: 32305868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
    Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
    Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity.
    Fan Y-C; Chen J-M; Chen Y-Y; Ke Y-D; Chang G-JJ; Chiou S-S
    J Virol; 2024 Apr; 98(4):e0177323. PubMed ID: 38530012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.
    Li Y; Counor D; Lu P; Duong V; Yu Y; Deubel V
    Virol J; 2012 Jul; 9():135. PubMed ID: 22828206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.